Specific social phobia
This article needs additional citations for verification. (August 2019) (Learn how and when to remove this template message)
Mental health professionals often distinguish between generalized social phobia and specific social phobia. People with generalized social phobia have great distress in a wide range of social situations. Those with specific social phobia may experience anxiety only in a few situations. The term "specific social phobia" may also refer to specific forms of non-clinical social anxiety.
The most common symptoms of specific social phobia are glossophobia, the fear of public speaking and the fear of performance, known as stage fright. Other examples of specific social phobia include fears of intimacy or sexual encounters, using public restrooms (paruresis), attending social gatherings, and dealing with authority figures.
Specific social phobia may be classified into performance fears and interaction fears, i.e., fears of acting in a social setting and interacting with other people, respectively. The cause of social phobia is not definite.
Symptoms of social phobia can occur in late adolescence when youths highly value the impressions they give off to their peers. Clinical experience of the prognosis of social phobia shows that it can prolong for many years but that it improves by mid life.
Treatment of social phobia usually involves psychotherapy, medication, or both.
This section needs expansion. You can help by adding to it. (October 2014)
Cognitive behavioral therapy (CBT) is commonly used to treat social phobia.
Anti-anxiety and antidepressant medication is commonly prescribed for treatment of social anxiety disorder. Selective serotonin reuptake inhibitors (SSRIs) such as sertraline, fluvoxamine and paroxetine are common medications which alleviate social phobia successfully in the short term but it is not certain if they are useful in the long-term. Also the MAOI moclobemide works well on treating social phobia in the short term. Patients who have avoided certain situations should make a big effort to become exposed to these situations while at the same time taking antidepressant medication. Anxiolytic medication aids a patient to handle social or professional situations before more lasting treatment has had an effect and therefore it is a provider of short term relief, but anxiolytics have a risk of dependence. Beta-adrenergic antagonists help to control palpitations and tremors unresponsive to the treatment of anxiolytic medication. One must read the precautions of these drugs outlined in the manufacturer's literature and be careful to watch out for the contraindications of these drugs.
Prevalence and distribution
In the past, when the prevalence was estimated by sampling the psychiatric clinical cases, social phobia was thought to be a rare disorder. It is now recognized that this way of estimating is inappropriate, because people with social phobia rarely seek psychiatric help by the very nature of their disorder. A more reliable source used now is community surveys.
Various surveys show that the syndrome of glossophobia is the most prevalent type. An article based on a National Comorbidity Survey reported that 1/3 of people with lifetime social phobia suffered from glossophobia Another survey of a community sample from a Canadian city reported that of people who believed being anxious in one or several social situations 55% feared speaking to a large audience, 25% feared speaking to a small group of familiar people, 23% feared dealing with authority, 14.5% feared social gatherings, 14% feared speaking to strangers, 7% feared eating and 5% feared writing in public.
- Crozier, W. Ray; Alden, Lynn E. International Handbook of Social Anxiety: Concepts, Research, and Interventions Relating to the Self and Shyness. New York John Wiley & Sons, Ltd. (UK), 2001. ISBN 0-471-49129-2.
- Michael G. Gelder; Richard Mayou; John Geddes (2005). Psychiatry. Oxford University Press. ISBN 978-0-19-852863-0. Retrieved 4 November 2010.
- M. B. Stein and J. M. Gorman, "Unmasking social anxiety disorder", J Psychiatry Neurosci. 2001 May; 26(3): 185–189.
- Ronald C. Kessler, Ph.D., Murray B. Stein, M.D., and Patricia Berglund, M.B.A. Social Phobia Subtypes in the National Comorbidity Survey, Am J Psychiatry 155:613-619, May 1998
- A survey by Dan Stein et al., as described in: Carlos Blanco, Carolina Garcia, Michael R. Liebowitz, "Epidemiology of Social Anxiety Disorder", in: Dan J. Stein, Borwin Bandelow (Eds.) "Social Anxiety Disorder", ISBN 0-8247-5454-9, p.38